デフォルト表紙
市場調査レポート
商品コード
1404794

水頭症シャントの市場規模、シェア、動向分析レポート:製品別、最終用途別、地域別、セグメント予測、2024年~2030年

Hydrocephalus Shunts Market Size, Share & Trends Analysis Report By Product (Valves, Catheter), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
水頭症シャントの市場規模、シェア、動向分析レポート:製品別、最終用途別、地域別、セグメント予測、2024年~2030年
出版日: 2023年11月28日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

水頭症シャント市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、水頭症シャントの世界市場規模は、2024年から2030年にかけて3.99%のCAGRで推移し、2030年には5億9,942万米ドルに達すると予測されています。

神経疾患治療に対する公的・民間資金の開拓、製品開発のための臨床研究の増加、製品上市のための規制承認の増加が市場成長の主な要因です。

業界の主なプレーヤーは、水頭症やその他の神経疾患の治療用デバイスの開発にも携わっています。製品ポートフォリオ開拓のための臨床研究の増加は、市場の成長をさらに促進します。例えば、2023年10月、伝達性水頭症の治療に対するデバイスの有効性を評価する進行中の臨床試験の一環として、CereVasc, Inc.は、節目となる30人目の患者がeShunt Implantを受けたことを明らかにしました。これらのパイロット試験のうち、最初の試験はアルゼンチンで医薬品・食品・医療機器管理局(ANMAT)の規制認可を受けて実施され、2番目の試験は米国でFDAの治験機器適用除外(IDE)の認可を受けて実施され、伝達性水頭症に対する低侵襲治療の研究が行われました。このように、臨床試験から得られた良好な結果が、近い将来の市場成長の原動力となるでしょう。

水頭症シャント市場レポートハイライト

  • 製品別では、バルブセグメントが2023年に71.26%のシェアで市場を独占しました。調整可能なバルブは、ヘルスケア専門家が患者の特定のニーズに応じて設定をカスタマイズすることを可能にし、それによって治療プロセスを最適化します。
  • 病院セグメントは、2023年にエンドユーザー市場全体の75.87%を占めました。手術、治療、処置のために入院する患者数の増加は、近い将来、水頭症シャントの需要を増加させると予想されています。
  • 北米は神経疾患と水頭症の罹患率が高いため、2023年の地域別市場全体の売上高シェアは37.97%で最も高かったです。
  • 水頭症シャント市場の主要企業には、Medtronic、Aesculap、Spiegelberg GmbH &Co.KG、Integra LifeSciences、Sophysa、CHRISTOPH MIETHKE GMBH &CO.KG、Hpbio、G. Surgiwear Ltd、Bicakcilar.

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 水頭症シャントの市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 水頭症シャント市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 水頭症シャント市場:製品の推定・動向分析

  • 定義と範囲
    • バルブ
    • カテーテル
  • 製品市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 製品別の水頭症シャント市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • バルブ
    • カテーテル

第5章 水頭症シャント市場:最終用途の推定・動向分析

  • 定義と範囲
    • 病院
    • 外来手術センター
  • 最終用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の水頭症シャント市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • 病院
    • 外来手術センター

第6章 水頭症シャント市場:地域の推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 地域市場シェアと主要企業、2023年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 市場年齢層、2018年から2030年までの予測と動向分析
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • インド
    • 中国
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • Sophysa
    • CHRISTOPH MIETHKE GMBH &CO. KG
    • Hpbio
    • G. Surgiwear Ltd
    • Bicakcilar
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global hydrocephalus shunts market, by region 2018 - 2030 (USD Million)
  • Table 4 Global hydrocephalus shunts market, by product 2018 - 2030 (USD Million)
  • Table 5 Global hydrocephalus shunts market, by end-use 2018 - 2030 (USD Million)
  • Table 6 North America hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Germany hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 France hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 21 France hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Italy hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Spain hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Sweden hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 27 Sweden hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Norway hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 29 Norway hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Denmark hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 31 Denmark hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 China hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 36 China hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 38 India hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hydrocephalus shunts market: Market snapshot
  • Fig. 9 Hydrocephalus shunts market: Market segmentation
  • Fig. 10 Hydrocephalus shunts market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Hydrocephalus shunts market driver impact
  • Fig. 14 Hydrocephalus shunts market restraint impact
  • Fig. 15 Hydrocephalus shunts market Porter's five forces analysis
  • Fig. 16 Hydrocephalus shunts market PESTEL analysis
  • Fig. 17 Hydrocephalus shunts market segment dashboard
  • Fig. 18 Hydrocephalus shunts market: Product movement Analysis
  • Fig. 19 Valves market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Catheter market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Hydrocephalus shunts market: End-use movement Analysis
  • Fig. 22 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global hydrocephalus shunts market: Regional movement analysis
  • Fig. 25 Global hydrocephalus shunts market: Regional outlook and key takeaways
  • Fig. 26 Global market share, by region
  • Fig. 27 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-157-3

Hydrocephalus Shunts Market Growth & Trends:

The global hydrocephalus shunts market size is anticipated to reach USD 599.42 million by 2030, registering at a CAGR of 3.99% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing public and private funding for neurological disorders treatments, increasing clinical studies for the product development, and the rise in regulatory approval for product launch are key contributors to the market growth.

The industry key players are also involved in developing devices for the treatment of hydrocephalus and other neurological disorders. The increasing clinical studies for the product portfolio development further drives the growth of the market. For instance, in October 2023, as part of the ongoing clinical trials evaluating the effectiveness of the device for the treatment of communicating hydrocephalus, CereVasc, Inc. revealed that a milestone 30th patient received the eShunt Implant. The first of these pilot studies, which was carried out in Argentina under regulatory approval from the National Administration of Drugs, Food and Medical Devices (ANMAT), and the second was executed in the U.S. under FDA approval for an Investigational Device Exemption (IDE) to study a minimally invasive treatment for communicating hydrocephalus. Thus, due to such positive outcomes from the clinical studies will drive the market growth in near future.

Hydrocephalus Shunts Market Report Highlights:

  • Based on product, valves segment dominated the market in 2023 with a share of 71.26%. Adjustable valves empower healthcare professionals to customize settings according to the patient's specific needs, thereby optimizing the treatment process.
  • The hospitals segment held 75.87% of the overall end user market in 2023. Increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for hydrocephalus shunts in near future.
  • North America dominated the overall regional market with the highest revenue share of 37.97% in 2023 owing to high incidence rate of neurological disease & hydrocephalus in this region.
  • Key players in hydrocephalus shunts market include Medtronic, Aesculap, Inc., Spiegelberg GmbH & Co. KG., Integra LifeSciences, Sophysa, CHRISTOPH MIETHKE GMBH & CO. KG, Hpbio, G. Surgiwear Ltd, and Bicakcilar.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Age group outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hydrocephalus Shunts Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increase in number of patients suffering from hydrocephalus
      • 3.4.1.2. Advancements in shunt technology
      • 3.4.1.3. Growing healthcare awareness
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Complex regulatory framework
  • 3.5. Hydrocephalus Shunts Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Hydrocephalus Shunts Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Valves
    • 4.1.2. Catheter
  • 4.2. Product Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Hydrocephalus Shunts Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Valves
      • 4.5.1.1. Valves market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Catheter
      • 4.5.2.1. Catheter market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Hydrocephalus Shunts Market: End Use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospitals
    • 5.1.2. Ambulatory Surgical Centers
  • 5.2. End Use Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Hydrocephalus Shunts Market by End-Use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospitals
      • 5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Ambulatory Surgical Centers
      • 5.5.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Hydrocephalus Shunts Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2023
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. Market Age Group, & Forecasts and Trend Analysis, 2018 to 2030
  • 6.6. North America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. U.S.
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.6.3. Canada
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.7. Europe
    • 6.7.1. UK
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.7.2. Germany
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.7.3. France
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.7.4. Italy
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.7.5. Spain
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.7.6. Denmark
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.7.7. Sweden
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive scenario
      • 6.7.7.3. Regulatory framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.7.8. Norway
      • 6.7.8.1. Key country dynamics
      • 6.7.8.2. Competitive scenario
      • 6.7.8.3. Regulatory framework
      • 6.7.8.4. Reimbursement scenario
      • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.8. Asia Pacific
    • 6.8.1. Japan
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.8.2. India
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.8.3. China
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.8.4. South Korea
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.8.5. Australia
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Competitive scenario
      • 6.8.5.3. Regulatory framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.8.6. Thailand
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Competitive scenario
      • 6.8.6.3. Regulatory framework
      • 6.8.6.4. Reimbursement scenario
      • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.9. Latin America
    • 6.9.1. Brazil
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.9.2. Mexico
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 6.9.3. Argentina
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.10. MEA
    • 6.10.1. South Africa
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Competitive scenario
      • 6.10.1.3. Regulatory framework
      • 6.10.1.4. Reimbursement scenario
      • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.10.2. Saudi Arabia
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Competitive scenario
      • 6.10.2.3. Regulatory framework
      • 6.10.2.4. Reimbursement scenario
      • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.10.3. UAE
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Competitive scenario
      • 6.10.3.3. Regulatory framework
      • 6.10.3.4. Reimbursement scenario
      • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.10.4. Kuwait
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Competitive scenario
      • 6.10.4.3. Regulatory framework
      • 6.10.4.4. Reimbursement scenario
      • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Aesculap, Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Spiegelberg GmbH & Co. KG.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Integra LifeSciences
      • 7.3.7.1. Company overview
      • . Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Sophysa
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. CHRISTOPH MIETHKE GMBH & CO. KG
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Hpbio
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. G. Surgiwear Ltd
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Bicakcilar
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives